Ascendis Pharma A/S
NASDAQ:ASND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ascendis Pharma A/S
NASDAQ:ASND
|
DK |
|
STERIS plc
NYSE:STE
|
IE |
|
Avis Budget Group Inc
NASDAQ:CAR
|
US |
|
General Electric Co
NYSE:GE
|
US |
|
National Grid PLC
LSE:NG
|
UK |
|
Mediaalpha Inc
NYSE:MAX
|
US |
|
Hiab Oyj
F:C1C1
|
FI |
|
F
|
Flywire Corp
NASDAQ:FLYW
|
US |
|
DTE Energy Co
NYSE:DTE
|
US |
|
First Citizens BancShares Inc (Delaware)
NASDAQ:FCNCA
|
US |
|
Cal-Maine Foods Inc
NASDAQ:CALM
|
US |
|
Systemair AB
STO:SYSR
|
SE |
|
Engie SA
PAR:ENGI
|
FR |
|
D
|
Danaher Corp
F:DAP
|
US |
|
L
|
Longino & Cardenal SpA
MIL:LON
|
IT |
|
Corporacion America Airports SA
NYSE:CAAP
|
LU |
|
TransDigm Group Inc
NYSE:TDG
|
US |
|
D
|
Directa SIM SpA
F:ZP7
|
IT |
|
C
|
Crown Castle Inc
SWB:8CW
|
US |
|
Fairfax Financial Holdings Ltd
TSX:FFH
|
CA |
|
L'Oreal SA
PAR:OR
|
FR |
|
Flex Ltd
NASDAQ:FLEX
|
SG |
|
CBAK Energy Technology Inc
NASDAQ:CBAT
|
CN |
|
A
|
Avi Ltd
JSE:AVI
|
ZA |
Bankruptcy Probability
Ascendis Pharma A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ascendis Pharma A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Ascendis Pharma A/S
NASDAQ:ASND
|
15B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
176.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
239.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ascendis Pharma A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ascendis Pharma A/S has total debt of 448.5m EUR. This includes both short-term (62.4m EUR) and long-term (386.1m EUR) debt.
You can find a full breakdown on its Balance Sheet.
